← FDA Drug Approvals (Drugs@FDA)
CYCLOSPORINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2023-01-12
Drug application
- FDA Application #
ANDA207606- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CYCLOSPORINE
- Generic name
- Cyclosporine
- Active ingredients
- CYCLOSPORINE
- Dosage form
- EMULSION
- Route
- OPHTHALMIC
- Marketing status
- Discontinued
- Sponsor
- APOTEX
- First approval
- 2023-01-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown